Advanced search
Start date
Betweenand

Characterization of epigenetics biomarkers of type 2 diabetes mellitus: identification of potential therapeutic targets of n-3 polyunsaturated fatty acids

Grant number: 15/12728-4
Support type:Regular Research Grants
Duration: May 01, 2016 - October 31, 2018
Field of knowledge:Biological Sciences - Physiology
Principal Investigator:Sandro Massao Hirabara
Grantee:Sandro Massao Hirabara
Home Institution: Pró-Reitoria de Pós-Graduação e Pesquisa. Universidade Cruzeiro do Sul (UNICSUL). São Paulo , SP, Brazil
Assoc. researchers:Renata Gorjao ; Rui Curi ; Tania Cristina Pithon Curi ; Tatiana Carolina Alba Loureiro
Associated scholarship(s):18/00998-5 - Characterization of epigenetic biomarkers of type 2 diabetes mellitus: identification of potential therapeutic targets of n-3 polyunsaturated fatty acids, BP.TT

Abstract

MicroRNAs (miRNAs) are involved in the control of energy metabolism and development of chronic diseases, such as obesity, T2DM, and metabolic syndrome. The identification of miRNAs associated with T2DM development is essential to understand the syndrome etiology and direct futher therapeutic studies. This project aims to characterize the expression profile of circulating exosomal miRNAs in T2DM subjects and identify the origin of these exosomal vesicles. We will evaluate: a) healthy individuals (normal glycemia and insulin sensitivity), b) glucose intolerant and insulin resistant subjects and c) newly diagnosed type 2 diabetic patients. The sample size will be calculated based on the initial results, considering alpha power of 0.05 and alterations of at least twice in expression of the miRNAs. The exosomal miRNAs profile will be evaluated by microarray PCR technique with quantitative validation by real time PCR. The characterization of the exosomal proteins will be established by proteomic analysis using mass spectrometry. Therefore, this study will be important for identifying and validating exossomal miRNAs as biomarkers of the T2DM development, as well as the origin of these exosomes and the modulation of this process by n-3 fatty acids, allowing the elucidation of the involvement of miRNAs on the diabetes development and the possible preventive and/or therapeutic effects of n-3 fatty acids. (AU)